Clinical Trial

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Study acronym: LeAAPS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
Protocol Amendment History 24 amendments
This ClinicalTrials.gov record has been amended 24 times since 2022-07-26; most recent amendment 2026-03-20.
Status change: Recruiting → Active, Not Recruiting 2025-08-11
Status change: Not Yet Recruiting → Recruiting 2023-02-03
Trial Details
NCT Number NCT05478304
Lead Sponsor AtriCure, Inc.
Collaborators: Population Health Research Institute
Conditions Ischemic Stroke, Systemic Embolism
Enrollment 6,573 participants
Start Date 2023-01-25
Primary Completion 2031-12 (estimated)
Study Completion 2032-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-24